Tennessee’s innovative clinical trials network is soaring just one year into operations, bringing growing benefits for Tennesseans and the advancement of health care across the state.
The Clinical Trials Network of Tennessee (CTN2), a research enterprise that operates as a subsidiary of UTRF, has already secured contracts to work with more than six medical institutions across the state since its launch in April 2018. As of this release, over 23 Tennesseans have enrolled as patients in CTN2 trials.
Learn how the network is a unique asset to Tennessee residents in the full press release.